aTyr Pharma ATYR Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about aTyr Pharma's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is aTyr Pharma's operating lease liabilities?
- aTyr Pharma (ATYR) reported operating lease liabilities of $10.06M in Q1 2026.
- How has aTyr Pharma's operating lease liabilities changed year-over-year?
- aTyr Pharma's operating lease liabilities decreased by 8.1% year-over-year, from $10.95M to $10.06M.
- What is the long-term trend for aTyr Pharma's operating lease liabilities?
- Over 5 years (2020 to 2025), aTyr Pharma's operating lease liabilities has grown at a 49.5% compound annual growth rate (CAGR), from $1.38M to $10.31M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.